Inactive Instrument

Positron Corp Stock Other OTC

US7373971099

Advanced Medical Equipment & Technology

End-of-day quote Other OTC
- ^USD	-

08-14	Positron Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-15	Positron Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Positron Corporation is a medical technology company focused to advancing the Positron Emission Tomography (PET) imaging modality through the development, manufacturing, and commercialization of its PET and PET-CT (Positron Emission Tomography/Computed Tomography) imaging systems along with providing comprehensive clinical services to nuclear medicine healthcare providers across North America. The Company specializes in the field of cardiac PET imaging, the gold standard in cardiac diagnostics. The Companyâ€™s imaging portfolio includes dedicated PET and 3D PET-CT 64-Slice systems, both designed to expand access to advanced molecular imaging. Additionally, it is preparing to introduce its 4D PET-CT 64-Slice scanner in nuclear cardiology. Its products, Attrius PET and NeuSight PET-CT 64- Slice scanner, provide a molecular imaging solution, enabling healthcare providers with diagnostic accuracy for cardiac and oncologic applications.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

As early as today, start finding the best investment opportunities!

Market Cap	58.73M 51.72M 49M 44.24M 83.38M 5.63B 84.46M 586M 226M 2.88B 221M 216M 9.23B	P/E 2024	-11x	P/E 2025	-4.87x
Enterprise Value	57.6M 50.72M 48.05M 43.38M 81.76M 5.52B 82.82M 575M 221M 2.82B 216M 212M 9.05B	EV / Sales 2024	49.4x	EV / Sales 2025	116x
Free-Float	45.36%	Yield 2024 *	-	Yield 2025	-

08-14	Positron Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-15	Positron Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-31	Positron Corporation Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-30	Positron Corporation Auditor Raises 'Going Concern' Doubt	CI
02-17	Positron Corporation Secures Multiple PET-CT Orders from Leading Nuclear Cardiology Practices	CI
12-22	Positron Corporation announced that it has received $2 million in funding	CI
11-12	Positron Corporation Reports Earnings Results for the Full Year Ended December 31, 2024	CI
11-11	Positron Corporation Auditor Raises 'Going Concern' Doubt	CI
25-10-02	Positron Corporation Enters Industry Partnership Agreement with MedAxiom	CI
25-08-22	Positron Corporation Announces New Corporate Headquarters and Strategic Redomiciling to Delaware	CI
25-08-13	Positron Corporation Secures Multi-Unit Sale of Pet-CT Scanners to Leading Cardiology Group	CI
25-05-29	Positron Corporation Expands Market Presence with Sale of NeuSight Pet-CT Scanner	CI
25-04-14	Positron Corporation Secures Agreement to Sell Four PET-CT Scanners	CI

07-20	Positron Secures Multiple PET-CT Orders Amid Accelerating Shift to Cardiac PET	GL
02-17	Positron Corporation Secures Multiple PET-CT Orders from Leading Nuclear Cardiologist Practices	GL
12-30	Positron Corporation Raises $2 Million to Expand Market Presence and Growth Initiatives	GL
11-17	Positron Corporation Announces Its Transition to a Reporting SEC Company	GL
25-10-02	Positron Corporation Enters Industry Partnership Agreement with MedAxiom	GL

Manager	Title	Age	Since
Adel Abdullah PSD	President	53	2018-02-26
Christopher Reilly SAM	Sales & Marketing	-	2022-06-23
Aaron Hargrave PRN	Corporate Officer/Principal	40	2018-05-24

Director	Title	Age	Since
Adel Abdullah CHM	Chairman	53	-
Tis Prager BRD	Director/Board Member	-	-

Positron Corp Stock Other OTC

Stocks

US7373971099

Advanced Medical Equipment & Technology

Valuation: Positron Corp

Latest news: Positron Corp

Press Releases: Positron Corp

Managers and Directors: Positron Corp

Medical Imaging Systems

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
THERMO FISHER SCIENTIFIC, INC.	-0.67%	+1.47%	+39.18%	+33.36%	251B
DANAHER CORPORATION	-1.84%	-0.00%	+11.75%	-10.70%	159B
INTUITIVE SURGICAL, INC.	-1.35%	+2.09%	-9.08%	+39.12%	146B
BOSTON SCIENTIFIC CORPORATION	-0.52%	-2.17%	-55.29%	-17.33%	63.59B
EDWARDS LIFESCIENCES CORPORATION	-2.00%	-0.58%	+10.99%	+24.60%	50.77B
AGILENT TECHNOLOGIES, INC.	-1.55%	+4.23%	+34.25%	+54.10%	49.35B
SIEMENS HEALTHINEERS AG	-1.76%	+2.07%	-17.49%	-20.90%	48.75B
VEEVA SYSTEMS INC.	+2.47%	+5.43%	-4.18%	+40.30%	45.1B
WATERS CORPORATION	-0.87%	+4.47%	+46.56%	+60.24%	43.55B
Average	-0.90%	+2.02%	+6.30%	+22.53%	95.22B
Weighted average by Cap.	-1.03%	+1.94%	+11.80%	+21.73%

	2024	2025
Net sales	588K 517K 490K 443K 834K 56.33M 845K 5.86M 2.26M 28.8M 2.21M 2.16M 92.33M	461K 406K 385K 348K 655K 44.25M 664K 4.61M 1.77M 22.62M 1.73M 1.69M 72.52M
Net income	-2.38M -2.1M -1.98M -1.79M -3.38M -228M -3.42M -23.75M -9.14M -117M -8.93M -8.74M -374M	-10.6M -9.34M -8.85M -7.99M -15.05M -1.02B -15.25M -106M -40.73M -520M -39.82M -38.95M -1.67B
Net Debt	1.42M 1.25M 1.19M 1.07M 2.02M 137M 2.05M 14.22M 5.47M 69.82M 5.35M 5.23M 224M	-1.14M -1M -948K -856K -1.61M -109M -1.63M -11.34M -4.36M -55.69M -4.27M -4.17M -179M